Publications by authors named "Raoul Concepcion"

38Publications

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

J Clin Oncol 2020 Aug 9;38(24):2798-2811. Epub 2020 Jun 9.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.00046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430215PMC
August 2020

Germline testing for prostate cancer: community urology perspective.

Can J Urol 2019 Oct;26(5 Suppl 2):50-51

Department of Urology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
October 2019

Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients.

Prostate Cancer Prostatic Dis 2019 12 12;22(4):588-592. Epub 2019 Apr 12.

Division of Medical Oncology, Departments of Medicine, Duke Prostate and Urologic Cancer Center, Duke University and the Duke Cancer Institute, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41391-019-0144-3
Publisher Site
http://dx.doi.org/10.1038/s41391-019-0144-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853838PMC
December 2019

Reply to M.A.N. Şendur et al and J. Michels.

J Clin Oncol 2017 01 31;35(1):123. Epub 2016 Oct 31.

David F. Penson, Vanderbilt University and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN; Andrew J. Armstrong, Duke University, Durham, NC; Raoul Concepcion, Urology Associates PC, Nashville, TN; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, Netherlands; and Celestia S. Higano, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.9371DOI Listing
January 2017

How Would You Manage?

Rev Urol 2016 ;18(1):44-5

Urology Associates, Nashville, Nashville, TN.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859929PMC
May 2016

Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.

J Clin Oncol 2016 06 25;34(18):2098-106. Epub 2016 Jan 25.

David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.9285DOI Listing
June 2016

A urologic oncology roundtable discussion: how to choose among the available therapies for the treatment of castration-resistant prostate cancer.

Postgrad Med 2013 Nov;125(6):114-6

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2013.11.2718DOI Listing
November 2013

Infusion therapy and implantables for the urologist.

Urol Clin North Am 2013 Nov;40(4):591-8

Department of Urology, University of California at Davis Medical Center, 4806 Y Street, Suite 2200, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2013.07.014DOI Listing
November 2013

Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Cancer Lett 2013 Jan 16;328(2):345-52. Epub 2012 Oct 16.

Vanderbilt University Medical Center, Division of Epidemiology, Nashville, TN 37203, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2012.10.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513505PMC
January 2013

Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.

BJU Int 2013 Jan 22;111(1):122-8. Epub 2012 Jun 22.

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203-1738, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11287.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460041PMC
January 2013

Obesity, body composition, and prostate cancer.

BMC Cancer 2012 Jan 18;12:23. Epub 2012 Jan 18.

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://bmccancer.biomedcentral.com/articles/10.1186/1471-240
Publisher Site
http://dx.doi.org/10.1186/1471-2407-12-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292483PMC
January 2012

Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer.

PLoS One 2011 Apr 25;6(4):e18237. Epub 2011 Apr 25.

Vanderbilt University Medical Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018237PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081812PMC
April 2011

The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.

Cancer Causes Control 2011 Mar 19;22(3):417-26. Epub 2010 Dec 19.

Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, 2525 West End Ave. 6th Floor, Suite 600, Nashville, TN 37203-1738, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-010-9713-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042514PMC
March 2011

Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.

J Urol 2009 May 14;181(5):2064-70. Epub 2009 Mar 14.

Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, Tennessee 37203-1738, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2009.01.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679527PMC
May 2009

Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.

Cancer Causes Control 2007 May 1;18(4):375-84. Epub 2007 Mar 1.

Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, 1215 21St Ave. South, Nashville, TN 37232-8300, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-007-0119-xDOI Listing
May 2007